Literature DB >> 34415349

Another Weak Link in the Electron Transport Chain: Variants in SUCLG2 and Risk for Pheochromocytoma and Paraganglioma.

Gina M Ney1, Douglas R Stewart1.   

Abstract

Entities:  

Mesh:

Year:  2022        PMID: 34415349      PMCID: PMC8755497          DOI: 10.1093/jnci/djab160

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


× No keyword cloud information.
  14 in total

1.  p53 Represses the Mevalonate Pathway to Mediate Tumor Suppression.

Authors:  Sung-Hwan Moon; Chun-Hao Huang; Shauna L Houlihan; Kausik Regunath; William A Freed-Pastor; John P Morris; Darjus F Tschaharganeh; Edward R Kastenhuber; Anthony M Barsotti; Rachel Culp-Hill; Wen Xue; Yu-Jui Ho; Timour Baslan; Xiang Li; Allison Mayle; Elisa de Stanchina; Lars Zender; David R Tong; Angelo D'Alessandro; Scott W Lowe; Carol Prives
Journal:  Cell       Date:  2018-12-20       Impact factor: 41.582

2.  Oncogenic Kras maintains pancreatic tumors through regulation of anabolic glucose metabolism.

Authors:  Haoqiang Ying; Alec C Kimmelman; Costas A Lyssiotis; Sujun Hua; Gerald C Chu; Eliot Fletcher-Sananikone; Jason W Locasale; Jaekyoung Son; Hailei Zhang; Jonathan L Coloff; Haiyan Yan; Wei Wang; Shujuan Chen; Andrea Viale; Hongwu Zheng; Ji-hye Paik; Carol Lim; Alexander R Guimaraes; Eric S Martin; Jeffery Chang; Aram F Hezel; Samuel R Perry; Jian Hu; Boyi Gan; Yonghong Xiao; John M Asara; Ralph Weissleder; Y Alan Wang; Lynda Chin; Lewis C Cantley; Ronald A DePinho
Journal:  Cell       Date:  2012-04-27       Impact factor: 41.582

3.  Germline SUCLG2 Variants in Patients With Pheochromocytoma and Paraganglioma.

Authors:  Katerina Hadrava Vanova; Ying Pang; Linda Krobova; Michal Kraus; Zuzana Nahacka; Stepana Boukalova; Svetlana D Pack; Renata Zobalova; Jun Zhu; Thanh-Truc Huynh; Ivana Jochmanova; Ondrej Uher; Sona Hubackova; Sarka Dvorakova; Timothy J Garrett; Hans K Ghayee; Xiaolin Wu; Bjoern Schuster; Philip E Knapp; Zdenek Frysak; Igor Hartmann; Naris Nilubol; Jiri Cerny; David Taieb; Jakub Rohlena; Jiri Neuzil; Chunzhang Yang; Karel Pacak
Journal:  J Natl Cancer Inst       Date:  2022-01-11       Impact factor: 13.506

Review 4.  International consensus on initial screening and follow-up of asymptomatic SDHx mutation carriers.

Authors:  Laurence Amar; Karel Pacak; Olivier Steichen; Scott A Akker; Simon J B Aylwin; Eric Baudin; Alexandre Buffet; Nelly Burnichon; Roderick J Clifton-Bligh; Patricia L M Dahia; Martin Fassnacht; Ashley B Grossman; Philippe Herman; Rodney J Hicks; Andrzej Januszewicz; Camilo Jimenez; Henricus P M Kunst; Dylan Lewis; Massimo Mannelli; Mitsuhide Naruse; Mercedes Robledo; David Taïeb; David R Taylor; Henri J L M Timmers; Giorgio Treglia; Nicola Tufton; William F Young; Jacques W M Lenders; Anne-Paule Gimenez-Roqueplo; Charlotte Lussey-Lepoutre
Journal:  Nat Rev Endocrinol       Date:  2021-05-21       Impact factor: 43.330

5.  α-Ketoglutarate links p53 to cell fate during tumour suppression.

Authors:  John P Morris; Jossie J Yashinskie; Richard Koche; Rohit Chandwani; Sha Tian; Chi-Chao Chen; Timour Baslan; Zoran S Marinkovic; Francisco J Sánchez-Rivera; Steven D Leach; Carlos Carmona-Fontaine; Craig B Thompson; Lydia W S Finley; Scott W Lowe
Journal:  Nature       Date:  2019-09-18       Impact factor: 69.504

6.  THE METABOLISM OF TUMORS IN THE BODY.

Authors:  O Warburg; F Wind; E Negelein
Journal:  J Gen Physiol       Date:  1927-03-07       Impact factor: 4.086

7.  Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.

Authors:  Sue Richards; Nazneen Aziz; Sherri Bale; David Bick; Soma Das; Julie Gastier-Foster; Wayne W Grody; Madhuri Hegde; Elaine Lyon; Elaine Spector; Karl Voelkerding; Heidi L Rehm
Journal:  Genet Med       Date:  2015-03-05       Impact factor: 8.822

8.  Metabolic heterogeneity confers differences in melanoma metastatic potential.

Authors:  Alpaslan Tasdogan; Brandon Faubert; Vijayashree Ramesh; Jessalyn M Ubellacker; Bo Shen; Ashley Solmonson; Malea M Murphy; Zhimin Gu; Wen Gu; Misty Martin; Stacy Y Kasitinon; Travis Vandergriff; Thomas P Mathews; Zhiyu Zhao; Dirk Schadendorf; Ralph J DeBerardinis; Sean J Morrison
Journal:  Nature       Date:  2019-12-18       Impact factor: 49.962

9.  Glutamine supports pancreatic cancer growth through a KRAS-regulated metabolic pathway.

Authors:  Jaekyoung Son; Costas A Lyssiotis; Haoqiang Ying; Xiaoxu Wang; Sujun Hua; Matteo Ligorio; Rushika M Perera; Cristina R Ferrone; Edouard Mullarky; Ng Shyh-Chang; Ya'an Kang; Jason B Fleming; Nabeel Bardeesy; John M Asara; Marcia C Haigis; Ronald A DePinho; Lewis C Cantley; Alec C Kimmelman
Journal:  Nature       Date:  2013-03-27       Impact factor: 49.962

10.  Cancer SLC43A2 alters T cell methionine metabolism and histone methylation.

Authors:  Yingjie Bian; Wei Li; Daniel M Kremer; Peter Sajjakulnukit; Shasha Li; Joel Crespo; Zeribe C Nwosu; Li Zhang; Arkadiusz Czerwonka; Anna Pawłowska; Houjun Xia; Jing Li; Peng Liao; Jiali Yu; Linda Vatan; Wojciech Szeliga; Shuang Wei; Sara Grove; J Rebecca Liu; Karen McLean; Marcin Cieslik; Arul M Chinnaiyan; Witold Zgodziński; Grzegorz Wallner; Iwona Wertel; Karolina Okła; Ilona Kryczek; Costas A Lyssiotis; Weiping Zou
Journal:  Nature       Date:  2020-09-02       Impact factor: 49.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.